Jenburkt Pharmaceuticals Buyback 2022 Details

Jenburkt Pharmaceuticals and markets pharmaceutical formulations in India and internationally across 13 countries. With over 850+ committed team members across functions pan-India, we promote all our 85 brands across 100,000+ doctors regularly. The company has more than 1,000 stockists and our reach extends to 400,000+ pharmacies across the globe. The organisation caters to large government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Our products are also being exported to 13 countries globally.

Read : Upcoming Buyback 2022

Jenburkt Pharmaceuticals Buyback 2022 Date & Details

Buyback Open Date 14 Dec 2022
Buyback Close Date 13 June 2023
Buyback Price 702 Rs
CMP 644 Rs
Issue Size 11.60 Crores
Security Name Jenburkt Pharmaceuticals Ltd
Face value 10
Listing At BSE,NSE
Issue Type Open Market Through Stock Exchange
Public Announcement Letter Download

Jenburkt Pharmaceuticals Contact Address

Jenburkt Pharmaceuticals Ltd
Nirmala Apartments, 93,
J. P. Road, Andheri (W),
Mumbai 400058,
Phone: +91 22 67603603
Email: [email protected]

Jenburkt Pharmaceuticals Buyback Manager

DAM Capital Advisors Limited
Address: One BKC, Tower C, 15th Floor, Unit No. 1511,
Bandra Kurla Complex, Bandra (East),
Mumbai 400 051, Maharashtra, India
Tel: +91 22 4202 2500;
Fax: +91 22-4202 2504;
Contact Person: Rajesh Tekadiwala
Email: [email protected]
SEBI Registration Number: INZ000207137
Validity Period: Permanent
CIN: U99999MH1993PLC071865

Jenburkt Pharmaceuticals Buyback Register

Bigshare Services Private Limited
Address : Office No S6-2, 6th Floor, Pinnacle Business
Park, Next to Ahura Centre, Mahakali
Caves Road, Andheri (East) Mumbai – 400093
Tel : 022 – 62638200
Fax : 022- 62638299
Contact Person : Swapnil Kate
Email ID : [email protected]
Website :
Number : INR000001385
Validity Period : Permanent
CIN : U99999MH1994PTC076534

Leave a Reply